Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KFN
6101
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
| $20K | ﹤0.01% |
+1,949
| New | +$20.4K |
2013 Q3
0 quarters
|
|
|
CSE
6102
PUT
DELISTED
CAPITALSOURCE INC
CSE
| $20K | ﹤0.01% |
1,700
-5,000
| -75% | -$56.6K |
2013 Q2
1 quarter
|
|
|
VRTB
6103
DELISTED
Vestin Realty Mortgage II, Inc.
VRTB
| $20K | ﹤0.01% |
+2,924
| New | +$19.4K |
2013 Q3
0 quarters
|
|
|
SVNT
6104
DELISTED
SAVIENT PHARMACEUTICALS INC
SVNT
| $20K | ﹤0.01% |
31,407
-44,191
| -58% | -$28.3K |
2013 Q2
1 quarter
|
|
|
MRGE
6105
PUT
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $20K | ﹤0.01% |
+7,600
| New | +$25.4K |
2013 Q3
0 quarters
|
|
|
EMXX
6106
DELISTED
Eurasian Minerals Inc
EMXX
| $20K | ﹤0.01% |
+16,090
| New | +$21.4K |
2013 Q3
0 quarters
|
|
|
TRIT
6107
DELISTED
TRI-TECH HLDG INC ORD SHS (KY)
TRIT
| $20K | ﹤0.01% |
+13,659
| New | +$19.7K |
2013 Q3
0 quarters
|
|
6108
PUT
American Homes 4 Rent
AMH
$10.9B
| $19K | ﹤0.01% |
+1,200
| New | +$19.2K |
2013 Q3
0 quarters
|
|
6109
Artivion
AORT
$1.09B
| $19K | ﹤0.01% |
+2,732
| New | +$18.5K |
2013 Q3
0 quarters
|
|
6110
CALL
Azenta
AZTA
$1.69B
| $19K | ﹤0.01% |
2,000
-100
| -5% | -$959 |
2013 Q2
1 quarter
|
|
6111
PUT
Ceragon Networks
CRNT
$200M
| $19K | ﹤0.01% |
+4,500
| New | +$16.1K |
2013 Q3
0 quarters
|
|
6112
PUT
FormFactor
FORM
$11.5B
| $19K | ﹤0.01% |
2,800
-7,200
| -72% | -$49K |
2013 Q2
1 quarter
|
|
6113
Inuvo
INUV
$9.44M
| $19K | ﹤0.01% |
+1,615
| New | +$16.4K |
2013 Q3
0 quarters
|
|
6114
INVE Technologies, Inc. Common Stock
INVE
$57.2M
| $19K | ﹤0.01% |
+2,727
| New | +$21K |
2013 Q3
0 quarters
|
|
|
MFA
6115
CALL
MFA Financial
MFA
$778M
| $19K | ﹤0.01% |
650
+350
| +117% | +$10.7K |
2013 Q2
1 quarter
|
|
6116
PUT
Mitek Systems
MITK
$805M
| $19K | ﹤0.01% |
3,600
-5,900
| -62% | -$32.2K |
2013 Q2
1 quarter
|
|
6117
PUT
Progressive
PGR
$121B
| $19K | ﹤0.01% |
700
-9,800
| -93% | -$254K |
2013 Q2
1 quarter
|
|
6118
CALL
Pluri
PLUR
$12.8M
| $19K | ﹤0.01% |
70
-50
| -42% | -$12.5K |
2013 Q2
1 quarter
|
|
6119
Siebert Financial
SIEB
$90.8M
| $19K | ﹤0.01% |
+11,138
| New | +$17.6K |
2013 Q3
0 quarters
|
|
6120
Solitario Resources
XPL
$56.1M
| $19K | ﹤0.01% |
+22,083
| New | +$20.7K |
2013 Q3
0 quarters
|
|
|
IRD
6121
Opus Genetics
IRD
$378M
| $19K | ﹤0.01% |
88
+28
| +47% | +$6.53K |
2013 Q2
1 quarter
|
|
|
ENG
6122
CALL
DELISTED
ENGlobal Corp
ENG
| $19K | ﹤0.01% |
2,475
+1,237
| +100% | +$10.8K |
2013 Q2
1 quarter
|
|
|
NURO
6123
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $19K | ﹤0.01% |
+4
| New | +$17.7K |
2013 Q3
0 quarters
|
|
|
ONCT
6124
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $19K | ﹤0.01% |
7
-6
| -46% | -$29.9K |
2013 Q2
1 quarter
|
|
|
CETV
6125
PUT
DELISTED
Central European Media Enterprises Ltd
CETV
| $19K | ﹤0.01% |
3,700
+400
| +12% | +$1.65K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.